Karin Rybak

ORCID: 0000-0003-1954-9688
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Heart Failure Treatment and Management
  • ECG Monitoring and Analysis
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac Imaging and Diagnostics
  • Healthcare Technology and Patient Monitoring
  • Cardiac Valve Diseases and Treatments
  • Acute Myocardial Infarction Research
  • Cardiac electrophysiology and arrhythmias
  • Medical Practices and Rehabilitation
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Pericarditis and Cardiac Tamponade
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Issues in Pregnancy
  • Cardiac Health and Mental Health
  • Mechanical Circulatory Support Devices
  • Health Systems, Economic Evaluations, Quality of Life
  • Erythropoietin and Anemia Treatment
  • Cardiac Structural Anomalies and Repair
  • Iron Metabolism and Disorders
  • Neurological disorders and treatments
  • Clinical practice guidelines implementation
  • Botulinum Toxin and Related Neurological Disorders

Saint Barnabas Medical Center
2024

Orthopädische Praxis
2011-2023

Praxis
2008-2019

Städtisches Klinikum Dessau
2017-2019

German Environment Agency
2016

Institute for Telematics
2010

Krankenhaus Köln-Holweide
2009

Angiologica (Italy)
2006

Hospital admissions are frequently preceded by increased pulmonary congestion in heart failure (HF) patients. This study evaluated whether early automated fluid status alert notification via telemedicine improves outcome HF Patients recently implanted with an implantable cardioverter defibrillator (ICD) or without cardiac resynchronization therapy were eligible if one of three conditions was met: prior hospitalization, recent diuretic treatment, brain natriuretic peptide increase. Eligible...

10.1093/eurheartj/ehw099 article EN European Heart Journal 2016-03-16

Impedance-based remote monitoring (RM) failed to reduce clinical events in the OptiLink heart failure (HF) trial. However, rates of alert-driven interventions triggered by intrathoracic fluid index threshold crossings (FTC) were low indicating physicians' inappropriate reactions alerts.We separated appropriate from contacts FTC transmissions HF trial (Optimization Heart Failure Management Using OptiVol™ Fluid Status Monitoring and CareLink™). Appropriate had meet following criteria: (1)...

10.1161/circep.120.008693 article EN Circulation Arrhythmia and Electrophysiology 2020-12-10

Abstract Aims Remote monitoring (RM) of thoracic impedance represents an early marker pulmonary congestion in heart failure (HF). Chronic kidney disease (CKD) may promote fluid overload HF patients. We investigated whether concomitant CKD affected the efficacy impedance‐based RM OptiLink trial. Methods and results Among patients included trial, time to first cardiovascular hospitalization all‐cause death according presence was analysed. defined as GFR < 60 mL/min/1.73 m 2 at enrolment. Of...

10.1002/ehf2.14387 article EN cc-by-nc ESC Heart Failure 2023-08-03

Es ist Wochenende. Kardiologe Dr. B. mit Praxis in Stuttgart macht eine Wanderung den Bayerischen Alpen. Bei der Mittagsjause auf 1200 Meter Höhe meldet sich die App seines Mobiltelefons einem Notruf: „Patient männlich, 55 Jahre, 30 % Risiko für inadäquate Schocks innerhalb nächsten 24 Stunden“. handelt um einen Patienten Kardiodefibrillator. Das eines inadäquaten Schockes bedeutet, dass Defibrillator irrtümlich von einer Indikation Schock zur Regularisierung Herztätigkeit des ausgeht. Kommt...

10.1055/s-0042-104771 article DE Aktuelle Kardiologie 2016-04-21

Aim: This study compares the outcomes of patients who receive an implantable loop recorder (ILR) for unexplained syncope to a control group without diagnostic device in German claims data. Methods and materials: Patients with ILR were matched based on prior events, age, gender Charlson Comorbidity index (CCI). Survival, hospitalizations, treatment costs compared. Results/conclusion: Four hundred twelve controls, mean age was 68, CCI 2.7, 42% females. lived average 1.2 years longer than...

10.2217/cer-2020-0242 article EN cc-by-nc-nd Journal of Comparative Effectiveness Research 2021-01-27

Therapy with implantable pacemakers, cardioverter defibrillators (ICD), and devices for cardiac resynchronization (CRT) is performed by various medical surgical specialists. With the change from implantation thoracotomy to transvenous approach, an increasing number of are implanted cardiologists. The purpose this paper establish training requirements device therapy, follow-up examinations, regardless implanting person, internist, cardiologist, general surgeon, or cardiothoracic surgeon....

10.1055/s-2008-1039175 article EN The Thoracic and Cardiovascular Surgeon 2009-01-23

Nahezu alle auf dem Markt befindlichen implantierbaren Rhythmusdevices eröffnen heute die Möglichkeit des Telemonitorings. Diese Option bietet Chance, Betreuung dieser Patienten sowohl unter ökonomischen als auch medizinischen und sicherheitstechnischen Aspekten zu optimieren. Die telemedizinische Überwachung von mit ICD- oder CRT-System fügt sich sinnvoll in das Konzept eines optimierten Herzinsuffizienzmanagements ein. Kardiologische Fachgesellschaften haben Devicemonitoring den aktuellen...

10.1055/s-0042-105078 article DE Aktuelle Kardiologie 2016-04-21

Palpitationen sind ein häufiges kardiales Symptom. Herzrhythmusstörungen die häufigste Ursache, gefolgt von psychosomatischen Erkrankungen. Die anamnestischen Angaben des Patienten zum Auftreten und zur Dauer der Symptome sowie Begleiterkrankungen erlauben häufig eine diagnostische Eingrenzung. Eine EKG-Aufzeichnung wird immer angestrebt, dafür Verfügung stehenden diagnostischen Methoden werden vorgestellt. Vorhofflimmern kann sowohl mit als auch ohne auftreten, Indikation oralen...

10.1055/s-0041-108910 article DE Aktuelle Kardiologie 2015-12-14
Coming Soon ...